R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00279-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanhae&utm_campaign=update-lanhae&utm_medium=email&_hsmi=285914520&_hsenc=p2ANqtz-_W5XW2vn9aoVZctxYnX56ZXUmoEuJ115iDPCiskaK0E5KIUtgfBzc_e7lro2D6FsE3lk0FR_ht0RSXoJVA0lO1B4NOow&utm_content=285757157&utm_source=hs_email